Urinary Tract Infection (UTI) Panel
Accurate identification of uropathogens for effective UTI treatment
Introduction
Advanced UTI DNA Detection
This molecular diagnostic test identifies DNA from common bacterial and fungal uropathogens directly from a urine sample, offering rapid and precise detection without the delays of traditional culture. It also screens for critical antibiotic resistance genes, enabling clinicians to make faster, more informed treatment decisions. By improving sensitivity and turnaround time, this test enhances care for patients with recurrent, complicated, or treatment-resistant UTIs.
Why the Test Is Significant
Rapid Pathogen Detection
Enables faster treatment through same-day results.
Resistance Marker Identification
Helps guide effective antibiotic selection quickly.
Superior Diagnostic Sensitivity
Detects organisms missed by standard cultures.
Ideal for Complex Infections
Supports care in recurrent and catheter-associated UTIs.
Unknown and Interesting Facts
Molecular UTI panels offer an advanced alternative to traditional cultures by detecting bacterial DNA—even from organisms that grow poorly or not at all in culture. This leads to more comprehensive detection, especially in patients pre-treated with antibiotics. Additionally, these panels often include antimicrobial resistance gene profiling, helping clinicians predict resistance patterns before full sensitivity reports are available, enabling faster and more precise therapy adjustments.
Medical Necessity and Signs/Symptoms
- Dysuria (pain or burning during urination)
- Increased frequency or urgency of urination
- Hematuria (blood in the urine)
- Flank or pelvic pain suggestive of upper tract involvement
- Recurrent UTIs or chronic urinary symptoms
- Complicated UTIs in males, pregnant women, or diabetics
- UTI symptoms in catheterized or immunocompromised patients
- Need for rapid, targeted antimicrobial treatment
Post-Test Support
Elite Clinical Laboratory provides rapid, reliable molecular UTI test results, clearly identifying detected organisms and key resistance markers. Our interpretation support helps clinicians select the most effective empiric or definitive therapy, minimizing delays in care and reducing inappropriate antibiotic use. With faster, more accurate information, clinicians can manage complex or high-risk UTI cases with greater confidence and precision.